| Artemisinin Resistance in Plasmodium falciparum Malaria AM Dondorp, F Nosten, P Yi, D Das, AP Phyo, J Tarning, KM Lwin, F Ariey, ... New England journal of medicine 361 (5), 455-467, 2009 | 4119 | 2009 |
| Spread of artemisinin resistance in Plasmodium falciparum malaria EA Ashley, M Dhorda, RM Fairhurst, C Amaratunga, P Lim, S Suon, ... New England Journal of Medicine 371 (5), 411-423, 2014 | 2429 | 2014 |
| Effect of hydroxychloroquine in hospitalized patients with Covid-19 RECOVERY Collaborative Group New England Journal of Medicine 383 (21), 2030-2040, 2020 | 1484 | 2020 |
| Dihydroartemisinin–piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study C Amaratunga, P Lim, S Suon, S Sreng, S Mao, C Sopha, B Sam, D Dek, ... The Lancet infectious diseases 16 (3), 357-365, 2016 | 498 | 2016 |
| Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological … RW van der Pluijm, M Imwong, NH Chau, NT Hoa, NT Thuy-Nhien, ... The Lancet infectious diseases 19 (9), 952-961, 2019 | 318 | 2019 |
| Evidence of Plasmodium falciparum malaria multidrug resistance to artemisinin and piperaquine in western Cambodia: dihydroartemisinin-piperaquine open-label multicenter … R Leang, WRJ Taylor, DM Bouth, L Song, J Tarning, MC Char, S Kim, ... Antimicrobial agents and chemotherapy 59 (8), 4719-4726, 2015 | 308 | 2015 |
| Reduced Susceptibility of Plasmodium falciparum to Artesunate in Southern Myanmar MP Kyaw, MH Nyunt, K Chit, MM Aye, KH Aye, MM Aye, N Lindegardh, ... PloS one 8 (3), e57689, 2013 | 256 | 2013 |
| Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label … RW van Der Pluijm, R Tripura, RM Hoglund, AP Phyo, D Lek, A Ul Islam, ... The Lancet 395 (10233), 1345-1360, 2020 | 225 | 2020 |
| Intrahost modeling of artemisinin resistance in Plasmodium falciparum S Saralamba, W Pan-Ngum, RJ Maude, SJ Lee, J Tarning, N Lindegårdh, ... Proceedings of the national academy of sciences 108 (1), 397-402, 2011 | 189 | 2011 |
| Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand J Tarning, EA Ashley, N Lindegardh, K Stepniewska, L Phaiphun, ... Antimicrobial agents and chemotherapy 52 (3), 1052-1061, 2008 | 153 | 2008 |
| Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria J Tarning, I Zongo, FA Some, N Rouamba, S Parikh, PJ Rosenthal, ... Clinical Pharmacology & Therapeutics 91 (3), 497-505, 2012 | 139 | 2012 |
| Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria J Tarning, MJ Rijken, R McGready, AP Phyo, W Hanpithakpong, NPJ Day, ... Antimicrobial agents and chemotherapy 56 (4), 1997-2007, 2012 | 135 | 2012 |
| Plasmodium falciparum Drug Resistance Phenotype as Assessed by Patient Antimalarial Drug Levels and Its Association With pfmdr1 Polymorphisms M Malmberg, PE Ferreira, J Tarning, J Ursing, B Ngasala, A Björkman, ... The Journal of infectious diseases 207 (5), 842-847, 2013 | 130 | 2013 |
| Screening of phytochemicals and in vitro evaluation of antibacterial and antioxidant activities of leaves, pods and bark extracts of Acacia nilotica (L.) Del. MB Sadiq, W Hanpithakpong, J Tarning, AK Anal Industrial crops and products 77, 873-882, 2015 | 120 | 2015 |
| The effect of dosing regimens on the antimalarial efficacy of dihydroartemisinin-piperaquine: a pooled analysis of individual patient data WorldWide Antimalarial Resistance Network (WWARN) DP Study Group PLoS medicine 10 (12), e1001564, 2013 | 120 | 2013 |
| Pharmacokinetics of high-dose oseltamivir in healthy volunteers Y Wattanagoon, K Stepniewska, N Lindegardh, S Pukrittayakamee, ... Antimicrobial agents and chemotherapy 53 (3), 945-952, 2009 | 117 | 2009 |
| The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concern R Abdelnabi, CS Foo, D Jochmans, L Vangeel, S De Jonghe, ... Nature Communications 13 (1), 719, 2022 | 116 | 2022 |
| COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology NJ White, JA Watson, RM Hoglund, XHS Chan, PY Cheah, J Tarning PLoS medicine 17 (9), e1003252, 2020 | 116 | 2020 |
| Population Pharmacokinetics of Lumefantrine in Pregnant Women Treated with Artemether-Lumefantrine for Uncomplicated Plasmodium falciparum Malaria J Tarning, R McGready, N Lindegardh, EA Ashley, M Pimanpanarak, ... Antimicrobial agents and chemotherapy 53 (9), 3837-3846, 2009 | 113 | 2009 |
| Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis LC Okell, M Cairns, JT Griffin, NM Ferguson, J Tarning, G Jagoe, P Hugo, ... Nature communications 5 (1), 5606, 2014 | 112 | 2014 |
Nicholas WhiteProfessor of Tropical Medicine, Mahidol and Oxford Universities在 tropmedres.ac 的电子邮件经过验证
